Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium.
Groen, J V
Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium. [electronic resource] - Annals of surgical oncology Nov 2018 - 3492-3501 p. digital
Publication Type: Journal Article; Multicenter Study; Observational Study
1534-4681
10.1245/s10434-018-6705-1 doi
Adenocarcinoma--mortality
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Chemotherapy, Adjuvant
Cohort Studies
Combined Modality Therapy
Data Collection
Europe
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoadjuvant Therapy--mortality
Neoplasm Staging
Pancreatectomy--mortality
Pancreatic Neoplasms--mortality
Survival Rate
Treatment Outcome
Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium. [electronic resource] - Annals of surgical oncology Nov 2018 - 3492-3501 p. digital
Publication Type: Journal Article; Multicenter Study; Observational Study
1534-4681
10.1245/s10434-018-6705-1 doi
Adenocarcinoma--mortality
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Chemotherapy, Adjuvant
Cohort Studies
Combined Modality Therapy
Data Collection
Europe
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoadjuvant Therapy--mortality
Neoplasm Staging
Pancreatectomy--mortality
Pancreatic Neoplasms--mortality
Survival Rate
Treatment Outcome